Key result
Totally endoscopic MVR for rheumatic disease requires ~86 cases to optimize aortic crossclamp times.
Why the study?
The safety, efficacy, and surgeon learning curve of totally endoscopic surgery for rheumatic mitral valve disease had not been fully evaluated.
What is the learning curve and safety profile of totally endoscopic surgery for rheumatic mitral valve disease?
Observational (n=242)
No
What is the learning curve and safety profile of totally endoscopic surgery for rheumatic mitral valve disease?
Totally endoscopic surgery for rheumatic mitral valve disease is safe and feasible, with a learning curve of 60 to 86 cases required to optimize operative times and manage complications.
Answers are grounded in this paper and cite their sources.
Should not yet change practice for rheumatic mitral disease; hypothesis-generating for the 60-86 case learning curve and needs prospective validation.
Objectives: This study evaluates the safety and efficacy of totally endoscopic surgery for rheumatic mitral valve disease (RMVD) and analyzes the learning curve using cumulative sum control chart (CUSUM) and risk-adjusted (RA)-CUSUM failure models. Methods: From March 2018 to November 2023, 242 consecutive patients with RMVD underwent totally endoscopic surgery via three 5.5-mm trocars and a 3- to 4-cm working port. Optimized management for atrial fibrillation (AF) included (1) mitral valve replacement, (2) tricuspid valve repair, (3) AF ablation, and (4) left atrial reduction. CUSUM and RA-CUSUM failure analyses were used to evaluate the learning curve progression, and comparisons were made between different learning curve phases. Results: and RA-CUSUM failure analyses in 130 patients demonstrated significant improvements in operative times and recovery across different learning curve phases. Conclusions: Totally endoscopic surgery for RMVD, including optimized AF management, is safe and feasible. Mastery of isolated endoscopic mitral valve replacement requires 86 cases to optimize aortic crossclamp time and 60 cases to effectively manage perioperative complications.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2025) conducted an observational in Rheumatic mitral valve disease (RMVD) (n=242). Totally endoscopic surgery was evaluated on Learning curve progression (operative times and recovery). Totally endoscopic mitral valve replacement for rheumatic disease requires 86 cases to optimize aortic crossclamp time and 60 cases to effectively manage perioperative complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: